Sylvain Fisson has not added Biography.
If you are Sylvain Fisson and would like to personalize this page please email our Author Liaison for assistance.
Continuous activation of autoreactive CD4+ CD25+ regulatory T cells in the steady state.
The Journal of experimental medicine Sep, 2003 | Pubmed ID: 12939344
Recipient-type specific CD4+CD25+ regulatory T cells favor immune reconstitution and control graft-versus-host disease while maintaining graft-versus-leukemia.
The Journal of clinical investigation Dec, 2003 | Pubmed ID: 14660744
Ex vivo selection of recipient-type alloantigen-specific CD4(+)CD25(+) immunoregulatory T cells for the control of graft-versus-host disease after allogeneic hematopoietic stem-cell transplantation.
Transplantation Jan, 2004 | Pubmed ID: 14726768
Identification of new CNS-resident macrophage subpopulation molecular markers for the discrimination with murine systemic macrophages.
Journal of neuroimmunology Dec, 2005 | Pubmed ID: 16169092
Natural regulatory T cells control the development of atherosclerosis in mice.
Nature medicine Feb, 2006 | Pubmed ID: 16462800
Therapeutic potential of self-antigen-specific CD4+ CD25+ regulatory T cells selected in vitro from a polyclonal repertoire.
European journal of immunology Apr, 2006 | Pubmed ID: 16525991
Regulatory T cells control uveoretinitis induced by pathogenic Th1 cells reacting to a specific retinal neoantigen.
Journal of immunology (Baltimore, Md. : 1950) Jun, 2006 | Pubmed ID: 16751360
Induction of antigen-specific tolerance by intrathymic injection of lentiviral vectors.
Blood Nov, 2006 | Pubmed ID: 16809618
Impaired th1/tc1 cytokine production of tumor-infiltrating lymphocytes in a model of primary intraocular B-cell lymphoma.
Investigative ophthalmology & visual science Jul, 2007 | Pubmed ID: 17591892
Expansion of CD4+CD25+ regulatory T cells by intravenous immunoglobulin: a critical factor in controlling experimental autoimmune encephalomyelitis.
Blood Jan, 2008 | Pubmed ID: 17932250
Animal models of intraocular lymphomas.
Ophthalmic research , 2008 | Pubmed ID: 18421241
Selective expression of inhibitory Fcgamma receptor by metastatic melanoma impairs tumor susceptibility to IgG-dependent cellular response.
International journal of cancer Dec, 2008 | Pubmed ID: 18798552
The future of primary intraocular lymphoma (retinal lymphoma).
Ocular immunology and inflammation Nov-Dec, 2009 | Pubmed ID: 20001255
Immune infiltration in human cancer: prognostic significance and disease control.
Current topics in microbiology and immunology , 2011 | Pubmed ID: 20512556
Tumor microenvironment is multifaceted.
Cancer metastasis reviews Mar, 2011 | Pubmed ID: 21271351
The immune microenvironments of lung and intraocular tumors.
Bulletin du cancer Jun, 2011 | Pubmed ID: 21616749
Th17 cells are involved in the local control of tumor progression in primary intraocular lymphoma.
PloS one , 2011 | Pubmed ID: 21949734
Murine models of B-cell lymphomas: promising tools for designing cancer therapies.
Advances in hematology , 2012 | Pubmed ID: 22400032
Influence of Tumor Location on the Composition of Immune Infiltrate and Its Impact on Patient Survival. Lessons from DCBCL and Animal Models.
Frontiers in immunology , 2012 | Pubmed ID: 22566974
Cytokine profile in human eyes: contribution of a new cytokine combination for differential diagnosis between intraocular lymphoma or uveitis.
PloS one , 2013 | Pubmed ID: 23405064
Lymphoma B-cell responsiveness to CpG-DNA depends on the tumor microenvironment.
Journal of experimental & clinical cancer research : CR , 2013 | Pubmed ID: 23561041
Preclinical study of Ublituximab, a Glycoengineered anti-human CD20 antibody, in murine models of primary cerebral and intraocular B-cell lymphomas.
Investigative ophthalmology & visual science May, 2013 | Pubmed ID: 23611989
Herpesvirus detection and cytokine levels (IL-10, IL-6, and IFN-γ) in ocular fluid from Tunisian immunocompetent patients with uveitis.
Journal of medical virology Dec, 2013 | Pubmed ID: 23960020
Immunization of mice with lentiviral vectors targeted to MHC class II+ cells is due to preferential transduction of dendritic cells in vivo.
PloS one , 2014 | Pubmed ID: 25058148
Mouse models of primary central nervous system lymphomas: tools for basing funding and therapeutic strategies.
Journal of neuro-oncology Jan, 2015 | Pubmed ID: 25300908
Treatment of Uveitis by In Situ Administration of Ex Vivo-Activated Polyclonal Regulatory T Cells.
Journal of immunology (Baltimore, Md. : 1950) Mar, 2016 | Pubmed ID: 26826251
ISOLD: A New Highly Sensitive Interleukin Score for Intraocular Lymphoma Diagnosis.
Ophthalmology Jul, 2016 | Pubmed ID: 26948307
JoVE 소개
Copyright © 2024 MyJoVE Corporation. 판권 소유